Tag: ARTIFICIAL INTELLIGENCE

Wesper to Unveil First Multi-Tier Sleep Diagnostic Ecosystem for Personalized Sleep Care at SLEEP 2026
Home Sleep Testing (HST) Product News

Wesper to Unveil First Multi-Tier Sleep Diagnostic Ecosystem for Personalized Sleep Care at SLEEP 2026

Wesper unveiled its multi-tier sleep diagnostic ecosystem at SLEEP 2026, the annual meeting of the Associated Professional Sleep Societies. The ecosystem brings two purpose-built diagnostic pathways, Wesper Lab and Wesper Lite, onto one platform, one patient record, and one interpretation pipeline, so physicians can match the right test to the right […]

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration
Artificial Intelligence Insomnia

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration

 Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]

New AI Technology to Speed Drug Development
Artificial Intelligence

New AI Technology to Speed Drug Development

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to […]

Exit 156 Capital and NightWare Announce Strategic Investment Partnership
Industry News Partnerships

NightWare Announce Strategic Investment Partnership

NightWare, Inc. and Exit 156 Capital announced a strategic investment by Exit 156 in NightWare’s ongoing Series C financing. NightWare is the maker of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The partnership unites a Minneapolis-based growth-stage digital health company […]

Sunrise Announces Landmark SUNSAS Trial Results, an At-Home Sleep Apnea Diagnostic Pathway Compared with PSG
Diagnostics & Testing Research & Studies Sleep Apnea

Sunrise’s AI-Powered Measure of Respiratory Effort, REMOV, Better Reflects OSA Symptoms Than Traditional PSG Metrics

Sunrise Group, a pioneer in medical device innovation and sleep care, today announced a new peer-reviewed study in Nature Communications Medicine. Sunrise developed the only home sleep test with respiratory effort measurement that has been validated against esophageal pressure, the reference standard. The study reveals that REMOV, the Sunrise-specific marker […]